BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 12164664)

  • 1. Immunity to Candida.
    Fidel PL
    Oral Dis; 2002; 8 Suppl 2():69-75. PubMed ID: 12164664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis.
    Leigh JE; Steele C; Wormley FL; Luo W; Clark RA; Gallaher W; Fidel PL
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):373-80. PubMed ID: 9833746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis.
    Fidel PL
    Adv Dent Res; 2006 Apr; 19(1):80-4. PubMed ID: 16672555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis.
    Leigh JE; Barousse M; Swoboda RK; Myers T; Hager S; Wolf NA; Cutright JL; Thompson J; Sobel JD; Fidel PL
    J Infect Dis; 2001 Jan; 183(2):277-285. PubMed ID: 11120933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct protective host defenses against oral and vaginal candidiasis.
    Fidel PL
    Med Mycol; 2002 Aug; 40(4):359-75. PubMed ID: 12230215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida-induced oral epithelial cell responses.
    Lilly EA; Leigh JE; Joseph SH; Fidel PL
    Mycopathologia; 2006 Jul; 162(1):25-32. PubMed ID: 16830188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis.
    Wozniak KL; Leigh JE; Hager S; Swoboda RK; Fidel PL
    J Infect Dis; 2002 May; 185(9):1269-76. PubMed ID: 12001044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oropharyngeal Candida colonization in human immunodeficiency virus infected patients.
    Li X; Lei L; Tan D; Jiang L; Zeng X; Dan H; Liao G; Chen Q
    APMIS; 2013 May; 121(5):375-402. PubMed ID: 23030258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis.
    Myers TA; Leigh JE; Arribas AR; Hager S; Clark R; Lilly E; Fidel PL
    Infect Immun; 2003 Feb; 71(2):956-63. PubMed ID: 12540578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral epithelial cell antifungal activity: approaches to evaluate a broad range of clinical conditions.
    Lilly EA; Shetty KV; Leigh JE; Cheeks C; Fidel PL
    Med Mycol; 2005 Sep; 43(6):517-23. PubMed ID: 16323309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis.
    Fidel PL
    Adv Dent Res; 2011 Apr; 23(1):45-9. PubMed ID: 21441480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis.
    Vultaggio A; Lombardelli L; Giudizi MG; Biagiotti R; Mazzinghi B; Scaletti C; Mazzetti M; Livi C; Leoncini F; Romagnani S; Maggi E; Piccinni MP
    Microbes Infect; 2008 Feb; 10(2):166-74. PubMed ID: 18249024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary cytokine profiles in the immunocompetent individual with Candida-associated denture stomatitis.
    Leigh JE; Steele C; Wormley F; Fidel PL
    Oral Microbiol Immunol; 2002 Oct; 17(5):311-4. PubMed ID: 12354213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathogenesis of recurrent vulvovaginal candidiasis.
    Fidel PL; Sobel JD
    Clin Microbiol Rev; 1996 Jul; 9(3):335-48. PubMed ID: 8809464
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Lomeli-Martinez SM; Valentin-Goméz E; Varela-Hernández JJ; Alvarez-Zavala M; Sanchez-Reyes K; Ramos-Solano M; Cabrera-Silva RI; Ramirez-Anguiano VM; Lomeli-Martinez MA; Martinez-Salazar SY; González-Hernández LA; Andrade-Villanueva JF
    Front Immunol; 2019; 10():1465. PubMed ID: 31316513
    [No Abstract]   [Full Text] [Related]  

  • 16. Host defense against oropharyngeal and vaginal candidiasis: Site-specific differences.
    Fidel PL
    Rev Iberoam Micol; 1999 Mar; 16(1):8-15. PubMed ID: 18473585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic immunosuppression by candida in HIV infection: a cytokine based analysis.
    Bajaj JS; Singh A; Aggarwal SK; Chattopadhya D; Baveja UK
    J Commun Dis; 2000 Mar; 32(1):1-9. PubMed ID: 11186879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-associated cytokine expression in HIV-positive persons with oropharyngeal candidiasis.
    Lilly EA; Hart DJ; Leigh JE; Hager S; McNulty KM; Mercante DE; Fidel PL
    J Infect Dis; 2004 Aug; 190(3):605-12. PubMed ID: 15243938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.
    Yano J; Noverr MC; Fidel PL
    Cytokine; 2012 Apr; 58(1):118-28. PubMed ID: 22182685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis.
    Fidel PL; Lynch ME; Sobel JD
    Infect Immun; 1995 Jul; 63(7):2403-8. PubMed ID: 7790050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.